Comparison of Haemodynamic Effects During Orotracheal Intubation, by Direct or Indirect Laryngoscopy With Airtraq
NCT ID: NCT03743831
Last Updated: 2020-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
218 participants
INTERVENTIONAL
2018-12-04
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Reasons why it decided to carry out this study, on the one hand to find these results and especially to be able to extend them to the whole population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Airtraq Versus Fiberoptic for Awake Tracheal Intubation
NCT03539185
Airway Injuries After Intubation Using Videolaryngoscopy Versus Direct Laryngoscopy for Adult Patients Requiring Tracheal Intubation
NCT03613103
Orotracheal Intubation in Adult Patients: A Comparison of Standard Airtraq , Nasotracheal Airtraq Combined With a Stylet Inserted Endotracheal Tube and Standard Airtraq Combined Fiberoptic Intubation
NCT03709524
Indirect Laryngoscopy for Nasal Intubation
NCT00910156
Intubation on a Paediatric Manikin by Emergency Staff: a Comparison of Airtraq and Glidescope
NCT02478203
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
orotracheal intubation direct
orotracheal intubation by direct laryngoscopy
Orotracheal intubation by direct laryngoscopy by metal blade type Macintosch
orotracheal intubation indirect
orotracheal intubation by indirect laryngoscopy
orotracheal intubation by indirect laryngoscopy by Airtraq
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
orotracheal intubation by direct laryngoscopy
Orotracheal intubation by direct laryngoscopy by metal blade type Macintosch
orotracheal intubation by indirect laryngoscopy
orotracheal intubation by indirect laryngoscopy by Airtraq
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient having given written consent to participate in the category 2 trial
* Intubation realized by experienced person
* Social Insured Patient
* Patient willing to comply with all procedures of the study and its duration
Exclusion Criteria
* Medical history: history of difficult intubation, hypertension
* Lille intubation score greater than or equal to 7
* Treatments in progress: Beta taking blocking the day of the operation.
* Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of coverage by the social security system, refusal to sign consent
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vygon GmbH & Co. KG
INDUSTRY
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elsa Jozefowicz, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Roger Salengro, CHU
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A01683-52
Identifier Type: OTHER
Identifier Source: secondary_id
2017_72
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.